TrialJournal for immunotherapy of cancer2025

Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study.

Francois Ghiringhelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.